Hepatitis E virus in Spanish donors and the necessity for screening.

Summary: Hepatitis E virus (HEV) represents a major health problem worldwide. As the course of HEV cases is often subclinical, asymptomatic infections could represent an important source of viral spread and infection via routes such as blood donations. Before universal screening for HEV in blood donations can be implemented, studies evaluating the incidence of infection are needed to establish the potential risk of viral transmission. This is a prospective longitudinal study that included blood donors recruited at the Hospital de Ciudad Real Transfusion Service between October 2017 and January 2018. Pools of eight donations were tested for HEV viremia by PCR. Positive pools were individually evaluated following the same procedure. Positive samples were tested for anti‐HEV IgG and IgM. Recipients of blood transfusions obtained from HEV‐positive donors were retrospectively evaluated. The prevalence of HEV was calculated. A total of 11 313 healthy donors were analysed during the study period. Four blood donations from four different donors were HEV RNA‐reactive. The prevalence of HEV infection was 0.035% (95% CI: 0.01%‐0.09%), which meant a ratio of one positive donation per 2828 donations. All donors were negative for anti‐HEV IgM at the time of the donation. Five patients received transfusions from HEV‐positive blood donations, none of them showed an increase in alanine aminotransferase levels after transfusion. In conclusion, our study found a high prevalence of HEV infection in blood donors from south‐central Spain. In view of the prevalence, Spanish blood banks should carefully consider including screening for HEV. [ABSTRACT FROM AUTHOR]